Journal articles on the topic 'Fusions ETS'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the top 50 journal articles for your research on the topic 'Fusions ETS.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.
Smith, Jenny L., Rhonda E. Ries, Yi-Cheng Wang, Amanda R. Leonti, Todd A. Alonzo, Alan S. Gamis, Richard Aplenc, et al. "ETS Family Transcription Factor Fusions in Childhood AML: Distinct Expression Networks and Clinical Implications." Blood 138, Supplement 1 (November 5, 2021): 2356. http://dx.doi.org/10.1182/blood-2021-148894.
Barbi de Moura, Michelle, Fadel S. Alyaqoub, Gargi D. Basu, David W. Hall, Jess R. Hoag, Janine R. LoBello, Frederick L. Baehner, Snehal Govind Thakkar, and Steven Canfield. "Erythroblast transformation-specific transcription factor fusions in prostate cancer." Journal of Clinical Oncology 41, no. 6_suppl (February 20, 2023): 224. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.224.
Staege, Martin S., and Daniela Max. "Genetics and Epigenetics of the TET-ETS Translocation Network." Genetics & Epigenetics 2 (January 2009): GEG.S2815. http://dx.doi.org/10.4137/geg.s2815.
Wei, Ting, Ji Lu, Tao Ma, Haojie Huang, Jean-Pierre Kocher, and Liguo Wang. "Re-Evaluate Fusion Genes in Prostate Cancer." Cancer Informatics 20 (January 2021): 117693512110275. http://dx.doi.org/10.1177/11769351211027592.
Gasi Tandefelt, Delila, Joost Boormans, Karin Hermans, and Jan Trapman. "ETS fusion genes in prostate cancer." Endocrine-Related Cancer 21, no. 3 (March 20, 2014): R143—R152. http://dx.doi.org/10.1530/erc-13-0390.
Anderson, Nathaniel D., Richard de Borja, Matthew D. Young, Fabio Fuligni, Andrej Rosic, Nicola D. Roberts, Simon Hajjar, et al. "Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors." Science 361, no. 6405 (August 30, 2018): eaam8419. http://dx.doi.org/10.1126/science.aam8419.
Buteyn, Nathaniel J., Connor Burke, Eve Gardner, Vincent J. Sartori, Rhonda E. Ries, Todd A. Alonzo, Soheil Meshinchi, and Timothy Triche. "Reclassification of ETS Family Transcription Factor Fusions in Pediatric AML Based on Molecular Drivers." Blood 142, Supplement 1 (November 28, 2023): 4298. http://dx.doi.org/10.1182/blood-2023-189474.
Lawlor, E. R., J. A. Mathers, T. Bainbridge, D. E. Horsman, A. Kawai, J. H. Healey, A. G. Huvos, J. A. Bridge, M. Ladanyi, and P. H. Sorensen. "Peripheral primitive neuroectodermal tumors in adults: documentation by molecular analysis." Journal of Clinical Oncology 16, no. 3 (March 1998): 1150–57. http://dx.doi.org/10.1200/jco.1998.16.3.1150.
Downing, Nicholas F., Kaitlyn M. Mills, and Peter C. Hollenhorst. "Abstract 3033: Oncogenic ETS transcription factors avoid repression by EZH2 and FOXO1 in prostate cancer and Ewing sarcoma." Cancer Research 84, no. 6_Supplement (March 22, 2024): 3033. http://dx.doi.org/10.1158/1538-7445.am2024-3033.
Clark, Jeremy P., and Colin S. Cooper. "ETS gene fusions in prostate cancer." Nature Reviews Urology 6, no. 8 (August 2009): 429–39. http://dx.doi.org/10.1038/nrurol.2009.127.
Deneen, Benjamin, Scott M. Welford, Thu Ho, Felicia Hernandez, Irwin Kurland, and Christopher T. Denny. "PIM3 Proto-Oncogene Kinase Is a Common Transcriptional Target of Divergent EWS/ETS Oncoproteins." Molecular and Cellular Biology 23, no. 11 (June 1, 2003): 3897–908. http://dx.doi.org/10.1128/mcb.23.11.3897-3908.2003.
Mani, Ram-Shankar, Scott A. Tomlins, Kaitlin Callahan, Aparna Ghosh, Mukesh K. Nyati, Sooryanarayana Varambally, Nallasivam Palanisamy, and Arul M. Chinnaiyan. "Induced Chromosomal Proximity and Gene Fusions in Prostate Cancer." Science 326, no. 5957 (October 29, 2009): 1230. http://dx.doi.org/10.1126/science.1178124.
Hussain, Maha, Stephanie Daignault-Newton, Przemyslaw W. Twardowski, Costantine Albany, Mark N. Stein, Lakshmi P. Kunju, Javed Siddiqui, et al. "Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012." Journal of Clinical Oncology 36, no. 10 (April 1, 2018): 991–99. http://dx.doi.org/10.1200/jco.2017.75.7310.
Zhang, Yue. "Article Commentary: ETS-FUSions Networking, Triggering and Beyond." Genetics & Epigenetics 3 (January 2010): GEG.S4166. http://dx.doi.org/10.4137/geg.s4166.
Feng, Felix Y., J. Chad Brenner, Maha Hussain, and Arul M. Chinnaiyan. "Molecular Pathways: Targeting ETS Gene Fusions in Cancer." Clinical Cancer Research 20, no. 17 (June 23, 2014): 4442–48. http://dx.doi.org/10.1158/1078-0432.ccr-13-0275.
Zou, Ying S., Laura Morsberger, Melanie Hardy, Jen Ghabrial, Victoria Stinnett, Jaclyn B. Murry, Patty Long, et al. "Complex/cryptic EWSR1::FLI1/ERG Gene Fusions and 1q Jumping Translocation in Pediatric Ewing Sarcomas." Genes 14, no. 6 (May 24, 2023): 1139. http://dx.doi.org/10.3390/genes14061139.
Yoshimoto, M., A. M. Joshua, S. Chilton-Macneill, J. Bayani, M. Prasad, N. Fleshner, A. Finelli, et al. "Detection of novel variant TMPRSS2 /ERG fusion transcripts suggests independent genomic alterations may underlie origin of multi-centric prostate cancer." Journal of Clinical Oncology 24, no. 18_suppl (June 20, 2006): 10029. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.10029.
He, Wei, Fukang Sun, Juping Zhao, Dai Jun, Le Xu, Chenghe Wang, Chen Fang, et al. "Prevalence and genetic features of TMPRSS2-ERG fusion in Chinese patients with prostate cancer." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e17529-e17529. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e17529.
Arvand, Afsane, and Christopher T. Denny. "Biology of EWS/ETS fusions in Ewing's family tumors." Oncogene 20, no. 40 (September 2001): 5747–54. http://dx.doi.org/10.1038/sj.onc.1204598.
Khosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D, and Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer." International Journal of Molecular Sciences 23, no. 9 (April 26, 2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Khosh Kish, Ealia, Muhammad Choudhry, Yaser Gamallat, Sabrina Marsha Buharideen, Dhananjaya D, and Tarek A. Bismar. "The Expression of Proto-Oncogene ETS-Related Gene (ERG) Plays a Central Role in the Oncogenic Mechanism Involved in the Development and Progression of Prostate Cancer." International Journal of Molecular Sciences 23, no. 9 (April 26, 2022): 4772. http://dx.doi.org/10.3390/ijms23094772.
Zhang, Zhusheng, Qiyuan Bao, Junxiang Wen, Zhuochao Liu, Qi Liu, Yuhui Shen, Lin Shao, Bing Li, Song-An Chen, and Weibin Zhang. "Abstract 4545: Integrative immune-genomic comparison of canonical Ewing sarcoma with Ewing-like mimics identifies potential targets for personalized therapies." Cancer Research 83, no. 7_Supplement (April 4, 2023): 4545. http://dx.doi.org/10.1158/1538-7445.am2023-4545.
Le Deley, Marie-Cecile, Olivier Delattre, Karl-Ludwig Schaefer, Sue A. Burchill, Gabriele Koehler, Pancras C. W. Hogendoorn, Thomas Lion, et al. "Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-E.W.I.N.G. 99 Trial." Journal of Clinical Oncology 28, no. 12 (April 20, 2010): 1982–88. http://dx.doi.org/10.1200/jco.2009.23.3585.
Anderson, Peter Meade, Luisa-Marie Manning, Brian Rubin, Timothy A. Chan, Scott E. Kilpatrick, Rabi Hanna, and Zheng Jin Tu. "Nested set information derived from fusion genes in Ewing sarcoma and other cancers." Journal of Clinical Oncology 40, no. 16_suppl (June 1, 2022): e23521-e23521. http://dx.doi.org/10.1200/jco.2022.40.16_suppl.e23521.
Feng, Felix Yi-Chung, Scott Tomlins, Mohammed Alshalalfa, Nicholas Erho, Kasra Yousefi, Shuang Zhao, Robert Benjamin Den, et al. "Molecular and clinical characterization of 1,577 primary prostate cancer tumors to reveal novel clinical and biological insights into its subtypes." Journal of Clinical Oncology 33, no. 7_suppl (March 1, 2015): 9. http://dx.doi.org/10.1200/jco.2015.33.7_suppl.9.
Smit, F. P., M. Salagierski, D. Hessels, S. A. Jannink, and J. A. Schalken. "786 IDENTIFICATION OF ETS GENE FUSIONS USING AFFYMETRIX EXON 1.0 ARRAYS." European Urology Supplements 8, no. 4 (March 2009): 317. http://dx.doi.org/10.1016/s1569-9056(09)60774-0.
Hammer, Liat, Ryan Rebernick, Matthew McFarlane, Thomas Westbrook, Munna Hazime, Tanya Hammoud, Pin-en Chiu, et al. "Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer." Journal of Clinical Oncology 41, no. 6_suppl (February 20, 2023): 263. http://dx.doi.org/10.1200/jco.2023.41.6_suppl.263.
Ho, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank, and Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling." Blood 93, no. 12 (June 15, 1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.
Ho, Jen M. Y., Bryan K. Beattie, Jeremy A. Squire, David A. Frank, and Dwayne L. Barber. "Fusion of the ets Transcription Factor TEL to Jak2 Results in Constitutive Jak-Stat Signaling." Blood 93, no. 12 (June 15, 1999): 4354–64. http://dx.doi.org/10.1182/blood.v93.12.4354.412k30_4354_4364.
Yaseen, Nabeel R., Akiko Takeda, Reza Nazari, Helen Shio, Gunter Blobel, and Hualin Zhong. "Carrier-Independent Nuclear Import of the Transcription Factor PU.1." Blood 104, no. 11 (November 16, 2004): 3561. http://dx.doi.org/10.1182/blood.v104.11.3561.3561.
Feng, F. Y., S. Han, C. Brenner, A. Sabolch, D. A. Hamstra, T. S. Lawrence, and A. Chinnaiyan. "PARP inhibition reverses radiation resistance conferred by ETS fusions in prostate cancer." Journal of Clinical Oncology 29, no. 15_suppl (May 20, 2011): 4545. http://dx.doi.org/10.1200/jco.2011.29.15_suppl.4545.
Tomlins, Scott A., Anders Bjartell, Arul M. Chinnaiyan, Guido Jenster, Robert K. Nam, Mark A. Rubin, and Jack A. Schalken. "ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice." European Urology 56, no. 2 (August 2009): 275–86. http://dx.doi.org/10.1016/j.eururo.2009.04.036.
Dong, Rongfang, Lan Li, Lihua Gong, Mengmeng Tian, Tingting Zhang, Wen Zhang, and Yi Ding. "Abstract 2152: Targetable oncogenic fusions and other alterations in bone and soft-tissue tumors assessed by RNA and DNA-based next-generation sequencing in real-world experience." Cancer Research 83, no. 7_Supplement (April 4, 2023): 2152. http://dx.doi.org/10.1158/1538-7445.am2023-2152.
Bilke, Sven, Raphaela Schwentner, Fan Yang, Maximilian Kauer, Gunhild Jug, Robert L. Walker, Sean Davis, et al. "Oncogenic ETS fusions deregulate E2F3 target genes in Ewing sarcoma and prostate cancer." Genome Research 23, no. 11 (August 12, 2013): 1797–809. http://dx.doi.org/10.1101/gr.151340.112.
Tomlins, Scott A., Bharathi Laxman, Saravana M. Dhanasekaran, Beth E. Helgeson, Xuhong Cao, David S. Morris, Anjana Menon, et al. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer." Nature 448, no. 7153 (August 2007): 595–99. http://dx.doi.org/10.1038/nature06024.
Dehm, Scott M. "Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer." Urologic Oncology: Seminars and Original Investigations 26, no. 6 (November 2008): 687–88. http://dx.doi.org/10.1016/j.urolonc.2008.09.003.
Dong, Jun, Li Xiao, Lu Sheng, Jun Xu, and Zhong-Quan Sun. "TMPRSS2:ETS Fusions and Clinicopathologic Characteristics of Prostate Cancer Patients from Eastern China." Asian Pacific Journal of Cancer Prevention 15, no. 7 (April 1, 2014): 3099–103. http://dx.doi.org/10.7314/apjcp.2014.15.7.3099.
Dan, Yuqing, Ruibao Ren, Donghe Li, and Ping Liu. "Novel Fusion Gene Aven-NUTM1 Induces Mice Myeloid Leukemia Vulnerable to HDAC Inhibitors." Blood 142, Supplement 1 (November 28, 2023): 4123. http://dx.doi.org/10.1182/blood-2023-188034.
Cools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer, and Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)." Blood 94, no. 5 (September 1, 1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.
Cools, Jan, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer, and Peter Marynen. "Fusion of a Novel Gene, BTL, to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)." Blood 94, no. 5 (September 1, 1999): 1820–24. http://dx.doi.org/10.1182/blood.v94.5.1820.417k09_1820_1824.
Thompson, Andrew D., Michael A. Teitell, Afsane Arvand, and Christopher T. Denny. "Divergent Ewing's sarcoma EWS/ETS fusions confer a common tumorigenic phenotype on NIH3T3 cells." Oncogene 18, no. 40 (September 1999): 5506–13. http://dx.doi.org/10.1038/sj.onc.1202928.
Braunreiter, Chi L., Jeffery D. Hancock, Cheryl Coffin, Kenneth M. Boucher, and Stephen L. Lessnick. "Expression of EWS-ETS Fusions in NIH3T3 Cells Reveals Significant Differences to Ewing’s Sarcoma." Cell Cycle 5, no. 23 (November 17, 2006): 2753–59. http://dx.doi.org/10.4161/cc.5.23.3505.
Paulo, Paula, João D. Barros-Silva, Franclim R. Ribeiro, João Ramalho-Carvalho, Carmen Jerónimo, Rui Henrique, Guro E. Lind, Rolf I. Skotheim, Ragnhild A. Lothe, and Manuel R. Teixeira. "FLI1 is a novel ETS transcription factor involved in gene fusions in prostate cancer." Genes, Chromosomes and Cancer 51, no. 3 (November 12, 2011): 240–49. http://dx.doi.org/10.1002/gcc.20948.
Seligson, Nathan David, Richard D. Maradiaga, Colin W. Stets, Howard Katzenstein, Sherri Z. Millis, John L. Hays, and James Lin Chen. "Multiscale omic assessment of EWSR1-NFATc2 fusion positive sarcomas to identify conserved fusion breakpoint and activation of the mTOR pathway." Journal of Clinical Oncology 38, no. 15_suppl (May 20, 2020): e23536-e23536. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e23536.
GUO, Xiao-Qiang, Yao-Ting GUI, and Zhi-Ming CAI. "The progress of TMPRSS2-ETS gene fusions and their mechanism in prostate cancer." Hereditas (Beijing) 33, no. 2 (May 5, 2011): 117–22. http://dx.doi.org/10.3724/sp.j.1005.2011.00117.
Pflueger, D., S. Terry, A. Sboner, L. Habegger, R. Esgueva, P. C. Lin, M. A. Svensson, et al. "Discovery of non-ETS gene fusions in human prostate cancer using next-generation RNA sequencing." Genome Research 21, no. 1 (October 29, 2010): 56–67. http://dx.doi.org/10.1101/gr.110684.110.
Miyagi, Yohei, Takeshi Sasaki, Kiyoshi Fujinami, Jinyu Sano, Yutaka Senga, Takeshi Miura, Yoichi Kameda, et al. "ETS family-associated gene fusions in Japanese prostate cancer: analysis of 194 radical prostatectomy samples." Modern Pathology 23, no. 11 (August 6, 2010): 1492–98. http://dx.doi.org/10.1038/modpathol.2010.149.
Xu, Kemin, Alexandra Budhai, Rugved Pattarkine, and Minghao Zhong. "Detecting FLI1 Fusion by Immunohistochemistry (IHC) Stain in Prostatic Adenocarcinoma." American Journal of Clinical Pathology 152, Supplement_1 (September 11, 2019): S72—S73. http://dx.doi.org/10.1093/ajcp/aqz113.087.
Nakagawa, Hidewaki. "Prostate cancer genomics by high-throughput technologies: genome-wide association study and sequencing analysis." Endocrine-Related Cancer 20, no. 4 (April 26, 2013): R171—R181. http://dx.doi.org/10.1530/erc-13-0113.
Morris, David S., Scott A. Tomlins, Daniel R. Rhodes, Jianjun Yu, Mark A. Rubin, Anders S. Bjartell, and Arul M. Chinnaiyan. "OUTLIER EXPRESSION OF SPINK1 IDENTIFIES AN AGGRESSIVE MOLECULAR SUBTYPE IN PROSTATE CANCERS WITHOUT ETS GENE FUSIONS." Journal of Urology 179, no. 4S (April 2008): 707. http://dx.doi.org/10.1016/s0022-5347(08)62060-1.